LifeMD, Inc.
LFMD
$3.84
-$0.09-2.29%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.95% | 17.69% | 48.83% | 43.23% | 37.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.95% | 17.69% | 48.83% | 43.23% | 37.96% |
| Cost of Revenue | 47.76% | 47.88% | 87.90% | 76.07% | 4.85% |
| Gross Profit | 9.34% | 14.45% | 44.28% | 38.78% | 42.64% |
| SG&A Expenses | 3.02% | 6.82% | 19.68% | 28.27% | 34.72% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 43.93% | 58.57% | 1.42% | 63.09% | 29.48% |
| Total Operating Expenses | 8.51% | 12.35% | 25.52% | 34.46% | 32.62% |
| Operating Income | 50.72% | 52.64% | 141.21% | 146.89% | 12.54% |
| Income Before Tax | 25.63% | 44.07% | 128.83% | 114.47% | 13.78% |
| Income Tax Expenses | -27.27% | -- | -- | -60.40% | -- |
| Earnings from Continuing Operations | 25.71% | 44.07% | 128.83% | 107.28% | 9.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -292.66% | -104.41% | -345.39% | 33.12% | 115.43% |
| Net Income | 18.29% | 36.79% | 120.46% | 97.15% | 23.92% |
| EBIT | 50.72% | 52.64% | 141.21% | 146.89% | 12.54% |
| EBITDA | 60.07% | 59.78% | 150.35% | 176.51% | 15.78% |
| EPS Basic | 23.20% | 36.69% | 107.33% | 82.97% | 35.38% |
| Normalized Basic EPS | 44.98% | 37.53% | 114.14% | 96.58% | 46.13% |
| EPS Diluted | 23.08% | 37.27% | 105.20% | 83.37% | 35.03% |
| Normalized Diluted EPS | 44.98% | 37.53% | 113.41% | 96.58% | 46.13% |
| Average Basic Shares Outstanding | 9.86% | 7.55% | 9.92% | 14.87% | 21.90% |
| Average Diluted Shares Outstanding | 9.86% | 7.55% | 16.15% | 14.87% | 21.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.22% | -0.58% | 5.89% | -34.12% | -0.31% |